Pneumocystosis: Survey in 14 hospitals from Assistance publique-Hôpitaux de Paris (AP-HP), France, 2003-2007;Réseau pneumocystose francilien : bilan de cinq années de surveillance (2003-2007)

Journal de Mycologie Medicale

Volumn 19, Issue 4, 2009, Pages 290-293

  Magne, D ^a   Angoulvant, A ^b   Botterel, F ^c   Bouges Michel, C ^d   Bougnoux, M E ^e   Bouree, P ⁿ   Brun, S ^f   Chochillon, C ^g   Cornet, M ^h   Dannaoui, E ⁱ   Datry, A ^f   Dunand, J ^m   Galeazzi, G ^j   Lebuisson, A ^k   Sarfati, C ^l   Roux, P ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL TENON   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d AVICENNE HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g BICHAT HOSPITAL   (France)

^h HÔTEL DIEU   (France)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^j HÔPITAL LOUIS MOURIER   (France)

^k NONE   (France)

^l SAINT LOUIS HOSPITAL   (France)

^m HÔPITAL AMBROISE PARÉ   (France)

ⁿ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

Corticotherapy; Cotrimoxazole; DHPS; Genotyping; HIV; Pneumocystosis; Prophylaxis

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DIHYDROPTEROATE SYNTHASE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RATE; KIDNEY TRANSPLANTATION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; POINT MUTATION;

EID: 70849127882     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2009.05.002     Document Type: Article

References (7)

1. Delfraissy JF (sous la direction de). Prise en charge des personnes infectées par le VIH. Recommandations du groupe d'experts, Rapport 2002. Éditions Médecine-Sciences Flammarion ; 1-402.
2. Magne D, Lacube P, Angoulvant A, Meliani L, Botterel F, Bougnoux ME, et al. Surveillance de la pneumocystose dans 14 hôpitaux de l'Assistance publique-Hôpitaux de Paris (AP-HP), France, 2003-2005. Bull Epidemiol Hebd, InVS, BEH 5-6 février 2007.
3. Meneau I., Sanglard D., Bille J., and Hauser P.M. Pneumocystis jirovecii dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob Agents Chemother 48 (2004) 2610-2616
4. Moukhlis R, Boyer J, Lacube P, Bolognini J, Roux P, Hennequin C. Linking Pneumocystis jirovecii sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae. Clin Microbiol Infect (sous presse).
5. Roblot F., Godet C., Le Moal G., Garo B., Faouzi Souala F., Dary M., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21 (2002) 523-531
6. Roux P., Ha M.C., Brucker G., and Costagliola D. Pneumocystis and pneumocystosis in Europe at the end of the 20th century. FEMS Immun Med Microbiol 22 (1998) 87-91
7. Stringer J., Beard C.B., Miller R.F., and Wakefield A.E. A new name (Pneumocystis jirovecii) for Pneumocystis from humans. Emerg Infect Dis 8 (2002) 891-896